Imperva (IMPV) Lowered to Buy at BidaskClub

BidaskClub lowered shares of Imperva (NASDAQ:IMPV) from a strong-buy rating to a buy rating in a report issued on Wednesday morning.

A number of other equities analysts have also recently issued reports on IMPV. ValuEngine raised shares of Imperva from a hold rating to a buy rating in a report on Thursday, October 11th. Morgan Stanley raised Imperva from an underweight rating to an equal weight rating and set a $56.00 target price on the stock in a report on Thursday, October 11th. Royal Bank of Canada decreased their price target on shares of Imperva to $56.00 and set an outperform rating on the stock in a research report on Thursday, October 11th. They noted that the move was a valuation call. Macquarie lowered shares of Imperva from an outperform rating to a neutral rating and set a $55.00 price target on the stock. in a research report on Thursday, October 11th. Finally, Evercore ISI restated a hold rating and issued a $55.75 price target on shares of Imperva in a research report on Thursday, October 11th. Ten analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Imperva currently has a consensus rating of Hold and an average target price of $56.37.

NASDAQ:IMPV traded up $0.01 during mid-day trading on Wednesday, reaching $55.74. The stock had a trading volume of 347,689 shares, compared to its average volume of 1,000,600. The company has a market capitalization of $1.96 billion, a price-to-earnings ratio of -199.07 and a beta of 1.09. Imperva has a 1-year low of $41.00 and a 1-year high of $57.65.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings results on Wednesday, October 31st. The software maker reported $0.43 EPS for the quarter, topping the Zacks’ consensus estimate of $0.18 by $0.25. The business had revenue of $91.63 million during the quarter, compared to the consensus estimate of $89.24 million. Imperva had a negative return on equity of 5.62% and a negative net margin of 8.00%. As a group, analysts expect that Imperva will post -1.06 earnings per share for the current fiscal year.

Hedge funds have recently added to or reduced their stakes in the stock. Public Employees Retirement Association of Colorado increased its holdings in shares of Imperva by 142.6% during the 3rd quarter. Public Employees Retirement Association of Colorado now owns 2,608 shares of the software maker’s stock worth $121,000 after purchasing an additional 1,533 shares during the period. Summit Global Investments increased its holdings in shares of Imperva by 14.2% during the 3rd quarter. Summit Global Investments now owns 15,300 shares of the software maker’s stock worth $711,000 after purchasing an additional 1,900 shares during the period. IndexIQ Advisors LLC increased its holdings in shares of Imperva by 3.9% during the 3rd quarter. IndexIQ Advisors LLC now owns 52,500 shares of the software maker’s stock worth $2,439,000 after purchasing an additional 1,983 shares during the period. Rhumbline Advisers increased its holdings in shares of Imperva by 6.6% during the 2nd quarter. Rhumbline Advisers now owns 33,741 shares of the software maker’s stock worth $1,628,000 after purchasing an additional 2,078 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in shares of Imperva by 1.4% during the 3rd quarter. Bank of New York Mellon Corp now owns 161,580 shares of the software maker’s stock worth $7,505,000 after purchasing an additional 2,231 shares during the period. 93.43% of the stock is owned by institutional investors and hedge funds.

About Imperva

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Further Reading: Market Capitalization and Individual Investors

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit